1289084-83-8

Usage

Uses

Used in Pharmaceutical Research:
(5-Bromo-3-fluoro-pyridin-2-yl)-hydrazine is used as a building block for the synthesis of complex organic molecules, particularly in the development of new pharmaceutical compounds. Its unique structure allows for the creation of diverse molecules with potential therapeutic applications.
Used in Chemical Research:
In the field of chemical research, (5-Bromo-3-fluoro-pyridin-2-yl)-hydrazine serves as a reagent in various chemical reactions. Its distinct properties make it a valuable component in the synthesis of novel compounds and the exploration of new reaction pathways.
Further research and development may reveal additional uses and potential benefits of this chemical compound, expanding its applications across different industries.

Upstream product

• 89402-44-8 5-bromo-2,3-difluoropyridine 
• 7803-57-8 hydrazine hydrate 

Downstream Products

• 1427473-77-5 6-bromo-8-fluoro-[1,2,4]triazolo[4,3-a]pyridin-3-thiol 

Relevant academic research and scientific papers

SUBSTITUTED FUSED HETEROCYCLES AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS

The present invention relates to substituted fused heterocyclic compounds. The substituted fused heterocyclic compounds are GPR1 19 modulators and useful for the prevention and/or treatment of diabetes, obesity, dyslipidemia and related disorders. The invention furthermore relates to the use of substituted fused heterocyclic compounds as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.

6 - SUBSTITUTED 3 - (QUINOLIN- 6 - YLTHIO) - [1,2,4] TRIAZOLO [4, 3 -A] PYRADINES AS TYROSINE KINASE

The invention relates to compounds of formula (I) and salts thereof: Formula (I) wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I).

TRIAZOLOPYRIDINE COMPOUNDS

The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound o f formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I)